- $50.69bn
- $50.73bn
- $5.50bn
- 100
- 12
- 86
- 72
2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | 2024 January 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 8-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,274 | 3,790 | 4,386 | 5,005 | 5,497 |
Cost of Revenue | |||||
Gross Profit | 2,949 | 3,453 | 3,968 | 4,525 | 4,986 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,931 | 3,161 | 3,769 | 4,016 | 4,369 |
Operating Profit | 343 | 629 | 618 | 989 | 1,128 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 295 | 547 | 565 | 946 | 1,136 |
Provision for Income Taxes | |||||
Net Income After Taxes | 224 | 1,208 | 497 | 823 | 906 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 215 | 1,208 | 497 | 823 | 906 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 215 | 1,208 | 497 | 823 | 906 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.1 | 5.4 | 2.75 | 4.72 | 4.37 |